NorthWest Biotherapeutics Inc (NWBO)

[vator]

If you are anticipating TLD to be good sitting at a base over $2 is not unimaginable because with good data in a major publication it will jump out of sight quick. If you expect the data to stink, volume will dry up again and we will probably head lower.

Tough call. I think the data will be good. It is up to the new investors to see the value. If the vaccine ends up treating all solid cancers, $2 will be minuscule as it plays out.